FR3059429B1 - PROCESS FOR IMPUTING A NON-NEGATIVE RESPONSE OBTAINED IN A REVERSE MUTATION TEST ON BACTERIA, CARRIED OUT FROM A PHARMACEUTICAL, COSMETIC OR NUTRITIONAL PREPARATION, AT LEAST ONE CONSTITUENT IDENTIFIED AS MUTAGEN IN VITRO - Google Patents

PROCESS FOR IMPUTING A NON-NEGATIVE RESPONSE OBTAINED IN A REVERSE MUTATION TEST ON BACTERIA, CARRIED OUT FROM A PHARMACEUTICAL, COSMETIC OR NUTRITIONAL PREPARATION, AT LEAST ONE CONSTITUENT IDENTIFIED AS MUTAGEN IN VITRO Download PDF

Info

Publication number
FR3059429B1
FR3059429B1 FR1661745A FR1661745A FR3059429B1 FR 3059429 B1 FR3059429 B1 FR 3059429B1 FR 1661745 A FR1661745 A FR 1661745A FR 1661745 A FR1661745 A FR 1661745A FR 3059429 B1 FR3059429 B1 FR 3059429B1
Authority
FR
France
Prior art keywords
bacteria
imputing
mutagen
cosmetic
vitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1661745A
Other languages
French (fr)
Other versions
FR3059429A1 (en
Inventor
Cecile Miette
Morcq Karine Ancolio
Didier Guedon
Philippe Abbe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Arkopharma SA
Original Assignee
Laboratoires Arkopharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Arkopharma SA filed Critical Laboratoires Arkopharma SA
Priority to FR1661745A priority Critical patent/FR3059429B1/en
Publication of FR3059429A1 publication Critical patent/FR3059429A1/en
Application granted granted Critical
Publication of FR3059429B1 publication Critical patent/FR3059429B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Procédé de préparation et de fractionnement d'une solution d'essai adaptée pour subir un test de mutation réverse sur bactéries en présence et/ou en absence d'activation métabolique exogène, et procédé permettant d'imputer une réponse non négative obtenue lors d'un premier test de mutation réverse sur bactéries.Process for preparing and fractionating a test solution suitable for undergoing a reverse mutation test on bacteria in the presence and / or absence of exogenous metabolic activation, and process for imputing a non-negative response obtained during a first reverse mutation test on bacteria.

FR1661745A 2016-11-30 2016-11-30 PROCESS FOR IMPUTING A NON-NEGATIVE RESPONSE OBTAINED IN A REVERSE MUTATION TEST ON BACTERIA, CARRIED OUT FROM A PHARMACEUTICAL, COSMETIC OR NUTRITIONAL PREPARATION, AT LEAST ONE CONSTITUENT IDENTIFIED AS MUTAGEN IN VITRO Active FR3059429B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1661745A FR3059429B1 (en) 2016-11-30 2016-11-30 PROCESS FOR IMPUTING A NON-NEGATIVE RESPONSE OBTAINED IN A REVERSE MUTATION TEST ON BACTERIA, CARRIED OUT FROM A PHARMACEUTICAL, COSMETIC OR NUTRITIONAL PREPARATION, AT LEAST ONE CONSTITUENT IDENTIFIED AS MUTAGEN IN VITRO

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1661745A FR3059429B1 (en) 2016-11-30 2016-11-30 PROCESS FOR IMPUTING A NON-NEGATIVE RESPONSE OBTAINED IN A REVERSE MUTATION TEST ON BACTERIA, CARRIED OUT FROM A PHARMACEUTICAL, COSMETIC OR NUTRITIONAL PREPARATION, AT LEAST ONE CONSTITUENT IDENTIFIED AS MUTAGEN IN VITRO
FR1661745 2016-11-30

Publications (2)

Publication Number Publication Date
FR3059429A1 FR3059429A1 (en) 2018-06-01
FR3059429B1 true FR3059429B1 (en) 2020-09-04

Family

ID=58054268

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1661745A Active FR3059429B1 (en) 2016-11-30 2016-11-30 PROCESS FOR IMPUTING A NON-NEGATIVE RESPONSE OBTAINED IN A REVERSE MUTATION TEST ON BACTERIA, CARRIED OUT FROM A PHARMACEUTICAL, COSMETIC OR NUTRITIONAL PREPARATION, AT LEAST ONE CONSTITUENT IDENTIFIED AS MUTAGEN IN VITRO

Country Status (1)

Country Link
FR (1) FR3059429B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3133860A1 (en) * 2022-03-23 2023-09-29 Genevolution Process for detecting the mutagenic nature of chemical compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE451474T1 (en) * 2003-04-26 2009-12-15 Merck & Co Inc FORWARD MUTATION TEST BASED ON 5-FLUORURACIL RESISTANCE
EP2258391A1 (en) * 2009-06-05 2010-12-08 Stallergenes S.A. Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids
FR2950532B1 (en) * 2009-09-30 2012-06-22 Natura Cosmeticos Sa PROCESS FOR THE PREPARATION OF AN EXTRACT OF PLANTS OF THE GENUS SCLEROLOBIUM, COSMETIC AND PHARMACEUTICAL COMPOSITION COMPRISING THIS EXTRACT AND THE USE OF SAID EXTRACT

Also Published As

Publication number Publication date
FR3059429A1 (en) 2018-06-01

Similar Documents

Publication Publication Date Title
EP4321627A3 (en) Spatially distinguished, multiplex nucleic acid analysis of biological specimens
BR112015026766A2 (en) hydroxycarboxylic acid processing for polymers
WO2016015058A3 (en) Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
FR3056989B1 (en) L-AMINO ACID PRODUCTION PROCESS
EP4296365A3 (en) Processes for conversion of biologically derived mevalonic acid
BR112017024654A2 (en) processes for producing methacrylic acid, fermentation medium, microorganism, recombinant microorganism, bioreactor, method for preparing polymers or copolymers of methacrylic acid or esters of methacrylic acid, and, polymethacrylic acid, polymethyl methacrylate and polybutyl methacrylate homopolymers or copolymers
MX2016009364A (en) Process for fractionation of oligosaccharides from agri-waste.
FR3046541B1 (en) ACTIVE PRINCIPLE OBTAINED FROM OPHIOPOGON JAPONICUS FOR THE TREATMENT OF ATOPIC DERMATITIS
PE20190517A1 (en) PHARMACEUTICAL PREPARATION ANTI-AGING
BR112019000975A2 (en) Single Use Food Preparation Container Method, System and Set
FR3059429B1 (en) PROCESS FOR IMPUTING A NON-NEGATIVE RESPONSE OBTAINED IN A REVERSE MUTATION TEST ON BACTERIA, CARRIED OUT FROM A PHARMACEUTICAL, COSMETIC OR NUTRITIONAL PREPARATION, AT LEAST ONE CONSTITUENT IDENTIFIED AS MUTAGEN IN VITRO
WO2016014612A3 (en) Compositions and methods for the diagnosis of rheumatoid arthritis
EP2690040A3 (en) Device for separating individual flat, flexible objects from the underside of a stack of such objects
FR2971719B1 (en) DEVICE FOR COATING A FLUID-PRODUCING OBJECT WITH AN ASSOCIATED DISTRIBUTION AND PROCESSING ASSEMBLY
BR112016028185A2 (en) method for producing an 1-amino acid.
WO2017205598A8 (en) Processing blood samples to detect target nucleic acids
FR2957076B1 (en) PROCESS FOR THE PRODUCTION OF PYRROLIDONECARBOXYLIC ACID OR A SALT THEREOF, PYRROLIDONECARBOXYLIC ACID SO OBTAINED AND COSMETIC CONTAINING THE SAME
FR3032198B1 (en) VALORIZATION OF NOBLE PRODUCTS IN A PROCESS FOR THE PRODUCTION OF (METH) ACRYLIC ESTER.
FR3016637B1 (en) GLYCOSAMINOGLYCANE IN VIVO PRODUCTION PROCESS
PL418557A1 (en) 4'-O-β-D-glucopyranosyl-4,2'-dihydroxy-3'-[3"-methylbutyl]-6'-methoxy-α,β-dihydrochalcone and method for obtaining 4'-O-β-D-glucopyranosyl-4,2'-dihydroxy-3'-[3"-methylbutyl]-6'-methoxy-α,β-dihydrochalcone
FR3080377B1 (en) PROCESS FOR PREPARING ALIPHATIC POLYESTERAMIDES
RU2012111034A (en) METHOD FOR DETERMINING THE NUMBER OF MICRO-ORGANISMS IN THE AIR
FR3049169B1 (en) PROCESS FOR THE PRODUCTION OF MILK SKIN AND THE FORMULATION OF FOODSTUFFS BASED ON MILK SKIN
BR112018074714B8 (en) PROCESS FOR FORMING NUTRITIONAL PRODUCTS ENRICHED WITH IRON
PL426668A1 (en) Method of separating alpha-ketoglutaric acid (AKG) out of actual post-fermentation liquids by bipolar membrane electrodialysis

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

EXTE Extension to a french territory

Extension state: PF

PLSC Publication of the preliminary search report

Effective date: 20180601

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8